- Mulberroside A
-
- $42.00 / 1mg
-
2025-12-26
- CAS:102841-42-9
- Min. Order:
- Purity: 99.40%
- Supply Ability: 10g
- Mulberroside A
-
- $0.00 / 25kg
-
2024-04-12
- CAS:102841-42-9
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- Mulberroside A
-
- $0.00 / 20mg
-
2023-02-24
- CAS:102841-42-9
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
| | mulberroside A Basic information |
| | mulberroside A Chemical Properties |
| Melting point | 235-236o C | | Boiling point | 954.7±65.0 °C(Predicted) | | density | 1.654 | | Fp | 531℃ | | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly, Sonicated), Methanol (Slightly) | | form | Solid | | pka | 9.03±0.40(Predicted) | | color | White to Off-White | | Cosmetics Ingredients Functions | SKIN CONDITIONING | | InChIKey | HPSWAEGGWLOOKT-WVRADKAPNA-N | | SMILES | O1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC1=CC=C(/C=C/C2C=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C(O)C=2)C(O)=C1 |&1:1,4,6,8,10,22,23,25,27,29,r| |
| | mulberroside A Usage And Synthesis |
| Description | Mulberroside A is isolated from the ethanol extract of Morus alba root. It has anti-tyrosinase and antioxidant activity and is widely used as an active ingredient in cosmetics. | | Chemical Properties | White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from Morus alba bark. | | Uses | Mulberroside A is a stilbenoid found in Morus alba plants. Potential metabolite for Oxyresveratrol (O861920), a natural hydroxystilbene with similar bioactivity to resveratrol. COX-1 inhibitor like resveratrol (R150000), anti-cancer agent. | | Definition | ChEBI: Cis-Mulberroside A is a glycoside and a stilbenoid. | | in vivo | Mulberroside A (10, 20, and 40 mg/kg) decreases serum uric acid levels and increases urinary urate excretion and fractional excretion of uric acid in hyperuricemic micem[4]. | Animal Model: | Male Kun-Ming mice (20±2 g)[4] | | Dosage: | 5, 10, 20, and 40 mg/kg; the dose volume 10 mL/kg body weight | | Administration: | Orally initiated at 9:00 a.m. | | Result: | 10, 20, and 40 mg/kg significantly increased urinary urate excretion in 24 h, resulting in a remarkable elevation of fractional excretion of uric acid (FEUA), and the highest dose completely reversed FEUA alteration of hyperuricemic mice to normal. |
| | IC 50 | IL-1β; IL-6 |
| | mulberroside A Preparation Products And Raw materials |
|